• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过重新启动肠道微生物群来平衡活性氧的产生。

Balancing reactive oxygen species generation by rebooting gut microbiota.

机构信息

Department of Medical Biotechnology, Maharshi Dayanand University, Rohtak, India.

Laboratory of Enzymology and Recombinant DNA Technology, Department of Microbiology, Maharshi Dayanand University, Rohtak, India.

出版信息

J Appl Microbiol. 2022 Jun;132(6):4112-4129. doi: 10.1111/jam.15504. Epub 2022 Mar 6.

DOI:10.1111/jam.15504
PMID:35199405
Abstract

Reactive oxygen species (ROS; free radical form O , superoxide radical; OH , hydroxyl radical; ROO , peroxyl; RO , alkoxyl and non-radical form O , singlet oxygen; H O , hydrogen peroxide) are inevitable companions of aerobic life with crucial role in gut health. But, overwhelming production of ROS can cause serious damage to biomolecules. In this review, we have discussed several sources of ROS production that can be beneficial or dangerous to the human gut. Micro-organisms, organelles and enzymes play crucial role in ROS generation, where NOX1 is the main intestinal enzyme, which produce ROS in the intestine epithelial cells. Previous studies have reported that probiotics play significant role in gut homeostasis by checking the ROS generation, maintaining the antioxidant level, immune system and barrier protection. With current knowledge, we have critically analysed the available literature and presented the outcome in the form of bubble maps to suggest that the probiotics help in controlling the ROS-specific intestinal diseases, such as inflammatory bowel disease (IBD) and colon cancer. Finally, it has been concluded that rebooting of the gut microbiota with probiotics, postbiotics or faecal microbiota transplantation (FMT) can have crucial implications in the structuring of gut communities for the personalized management of the gastrointestinal (GI) diseases.

摘要

活性氧(ROS;自由基形式 O ,超氧自由基;OH ,羟基自由基;ROO ,过氧自由基;RO ,烷氧自由基和非自由基形式 O ,单线态氧;H 2 O 2 ,过氧化氢)是需氧生命的必然伴随物,在肠道健康中起着至关重要的作用。但是,ROS 的过度产生会对生物分子造成严重的损害。在这篇综述中,我们讨论了 ROS 产生的几个来源,这些来源对人类肠道可能有益,也可能有害。微生物、细胞器和酶在 ROS 产生中起着至关重要的作用,其中 NADPH 氧化酶 1(NOX1)是主要的肠道酶,它在肠道上皮细胞中产生 ROS。先前的研究报告表明,益生菌通过检查 ROS 的产生、维持抗氧化水平、免疫系统和屏障保护,在肠道稳态中发挥重要作用。根据现有知识,我们对现有文献进行了批判性分析,并以气泡图的形式呈现了结果,表明益生菌有助于控制特定于肠道的疾病,如炎症性肠病(IBD)和结肠癌。最后得出的结论是,益生菌、后生元和粪便微生物群移植(FMT)对肠道微生物群的重新启动可能对肠道群落的结构具有重要意义,从而实现胃肠道(GI)疾病的个体化管理。

相似文献

1
Balancing reactive oxygen species generation by rebooting gut microbiota.通过重新启动肠道微生物群来平衡活性氧的产生。
J Appl Microbiol. 2022 Jun;132(6):4112-4129. doi: 10.1111/jam.15504. Epub 2022 Mar 6.
2
Inflammatory Bowel Diseases and Gut Microbiota.炎症性肠病与肠道微生物群。
Int J Mol Sci. 2023 Feb 14;24(4):3817. doi: 10.3390/ijms24043817.
3
Can control of gut microbiota be a future therapeutic option for inflammatory bowel disease?肠道微生物组的控制能否成为炎症性肠病的未来治疗选择?
World J Gastroenterol. 2021 Jun 21;27(23):3317-3326. doi: 10.3748/wjg.v27.i23.3317.
4
Gut microbiota in the pathogenesis of inflammatory bowel disease.肠道微生物群在炎症性肠病发病机制中的作用
Clin J Gastroenterol. 2018 Feb;11(1):1-10. doi: 10.1007/s12328-017-0813-5. Epub 2017 Dec 29.
5
Hepatic drug metabolism and gut microbiome.肝脏的药物代谢与肠道微生物组。
Prog Mol Biol Transl Sci. 2022;191(1):207-228. doi: 10.1016/bs.pmbts.2022.07.005. Epub 2022 Sep 3.
6
Gut microbiota and inflammatory bowel disease: so far so gut!肠道微生物群与炎症性肠病:迄今为止,肠道的情况就是这样!
Minerva Gastroenterol Dietol. 2017 Dec;63(4):373-384. doi: 10.23736/S1121-421X.17.02386-8. Epub 2017 Mar 14.
7
The role of the gut microbiota in the treatment of inflammatory bowel diseases.肠道微生物群在炎症性肠病治疗中的作用。
Microb Pathog. 2019 Dec;137:103774. doi: 10.1016/j.micpath.2019.103774. Epub 2019 Oct 3.
8
Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.目前对微生物群和饮食疗法治疗炎症性肠病的理解。
J Microbiol. 2018 Mar;56(3):189-198. doi: 10.1007/s12275-018-8049-8. Epub 2018 Feb 28.
9
Gut microbiota in inflammatory bowel disease: a target for therapy not to be missed.炎症性肠病中的肠道微生物群:一个不容错过的治疗靶点。
Minerva Gastroenterol (Torino). 2021 Dec;67(4):357-368. doi: 10.23736/S2724-5985.21.02907-7.
10
Hierarchical multi-task deep learning-assisted construction of human gut microbiota reactive oxygen species-scavenging enzymes database.基于分层多任务深度学习的人类肠道微生物群活性氧清除酶数据库构建。
mSphere. 2024 Jul 30;9(7):e0034624. doi: 10.1128/msphere.00346-24. Epub 2024 Jul 12.

引用本文的文献

1
Balancing Oxidative Stress: How the Gut Microbiome Supports Redox Homeostasis and Mitochondrial Health.平衡氧化应激:肠道微生物群如何支持氧化还原稳态和线粒体健康。
J Restor Med. 2025;15(1):4-19. doi: 10.14200/jrm.2025.0002. Epub 2025 Jun 5.
2
Wine-Processed Polysaccharides Alleviating Cognitive Dysfunction in CUMS Mice by Regulating Intestinal Microbiota.酒制多糖通过调节肠道菌群减轻慢性不可预知温和应激小鼠的认知功能障碍
Food Sci Nutr. 2025 Aug 8;13(8):e70711. doi: 10.1002/fsn3.70711. eCollection 2025 Aug.
3
Space-driven ROS in cells: a hidden danger to astronaut health and food safety.
细胞中的空间驱动活性氧:对宇航员健康和食品安全的潜在威胁。
NPJ Microgravity. 2025 Aug 4;11(1):52. doi: 10.1038/s41526-025-00492-x.
4
Cyclodextrins as Modulators of Gut Microbiota: Pharmaceutical Applications and Impact on Intestinal Health.环糊精作为肠道微生物群调节剂:药物应用及其对肠道健康的影响
Pharmaceutics. 2025 Jun 7;17(6):752. doi: 10.3390/pharmaceutics17060752.
5
Biological properties, synthetic pathways and anti-aging mechanisms of nicotinamide mononucleotide (NMN): Research progress and challenges.烟酰胺单核苷酸(NMN)的生物学特性、合成途径及抗衰老机制:研究进展与挑战
Biogerontology. 2025 Jun 23;26(4):124. doi: 10.1007/s10522-025-10270-7.
6
Muscone Ameliorates High-Altitude Hypoxia Gastrointestinal Stress via Modulation of Lactobacillus Murinus and Mitochondrial Metabolism.麝香酮通过调节鼠李糖乳杆菌和线粒体代谢改善高原缺氧胃肠道应激。
J Inflamm Res. 2025 May 26;18:6683-6701. doi: 10.2147/JIR.S521991. eCollection 2025.
7
Subsp. LL-1 and LP-16 Influence the Gut Microbiota and Metabolites for Anti-Obesity and Hypolipidemic Effects in Mice.亚种LL-1和LP-16影响小鼠肠道微生物群和代谢产物,具有抗肥胖和降血脂作用。
Antioxidants (Basel). 2025 May 1;14(5):547. doi: 10.3390/antiox14050547.
8
Gut microbiota-mitochondrial crosstalk in obesity: novel mechanistic insights and therapeutic strategies with traditional Chinese medicine.肥胖中肠道微生物群与线粒体的相互作用:基于中药的新机制见解与治疗策略
Front Pharmacol. 2025 Apr 22;16:1574887. doi: 10.3389/fphar.2025.1574887. eCollection 2025.
9
Exploring the Influence of a Pomegranate Extract on the Functionality of Healthy and Diseased Human Gut Microbiota: An In Vitro Study.探索石榴提取物对健康和患病人类肠道微生物群功能的影响:一项体外研究。
Molecules. 2025 Apr 6;30(7):1634. doi: 10.3390/molecules30071634.
10
Gut Microbiota Serves as a Crucial Independent Biomarker in Inflammatory Bowel Disease (IBD).肠道微生物群是炎症性肠病(IBD)中一个关键的独立生物标志物。
Int J Mol Sci. 2025 Mar 11;26(6):2503. doi: 10.3390/ijms26062503.